Your browser doesn't support javascript.
loading
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.
Moutafi, Myrto; Koliou, Georgia-Angeliki; Papaxoinis, George; Economopoulou, Panagiota; Kotsantis, Ioannis; Gkotzamanidou, Maria; Anastasiou, Maria; Pectasides, Dimitrios; Kyrodimos, Efthymios; Delides, Alexander; Giotakis, Evangelos; Papadimitriou, Nikolaos G; Panayiotides, Ioannis G; Perisanidis, Christos; Fernandez, Aileen I; Xirou, Vasiliki; Poulios, Christos; Gagari, Eleni; Yaghoobi, Vesal; Gavrielatou, Niki; Shafi, Saba; Aung, Thazin Nwe; Kougioumtzopoulou, Andromachi; Kouloulias, Vassilis; Palialexis, Konstantinos; Gkolfinopoulos, Stavros; Strati, Areti; Lianidou, Evi; Fountzilas, George; Rimm, David L; Foukas, Periklis G; Psyrri, Amanda.
Afiliação
  • Moutafi M; Second Department of Internal Medicine, Medical Oncology Section, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Koliou GA; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Papaxoinis G; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Economopoulou P; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
  • Kotsantis I; Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece.
  • Gkotzamanidou M; Second Department of Internal Medicine, Medical Oncology Section, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Anastasiou M; Second Department of Internal Medicine, Medical Oncology Section, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Pectasides D; Second Department of Internal Medicine, Medical Oncology Section, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Kyrodimos E; Second Department of Internal Medicine, Medical Oncology Section, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Delides A; Second Department of Internal Medicine, Medical Oncology Section, Hippokration General Hospital, Athens, Greece.
  • Giotakis E; Department of Otolaryngology-Head and Neck Surgery, Hippokration General Hospital, University of Athens, Athens, Greece.
  • Papadimitriou NG; Second Otolaryngology Department, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Panayiotides IG; Department of Otolaryngology-Head and Neck Surgery, Hippokration General Hospital, University of Athens, Athens, Greece.
  • Perisanidis C; Second Otolaryngology Department, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Fernandez AI; Second Department of Pathology, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Xirou V; Department of Oral and Maxillofacial Surgery, School of Dentistry, National and Kapodistrian University of Athens, Athens, Greece.
  • Poulios C; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Gagari E; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Yaghoobi V; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Gavrielatou N; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Shafi S; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Aung TN; Oral Medicine Clinics, A. Syggros Hospital of Dermatologic and Venereal Diseases, Department of Dermatology, School of Medicine, University of Athens, Athens, Greece.
  • Kougioumtzopoulou A; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Kouloulias V; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Palialexis K; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Gkolfinopoulos S; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Strati A; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Lianidou E; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Fountzilas G; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Rimm DL; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Foukas PG; Second Department of Radiology, Radiotherapy Unit, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Psyrri A; Second Department of Radiology, Radiotherapy Unit, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
Cancer Res Commun ; 3(8): 1514-1523, 2023 08.
Article em En | MEDLINE | ID: mdl-37575280

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article